Full-Time
Clinical Pharmacology Fellow
Pioneering precision genetic medicines through CRISPR base editing
Entry, Junior
Cambridge, MA, USA
- Engage in extensive data analysis, visualization, and presentation of data derived from nonclinical and clinical studies or literature
- Collaboratively design nonclinical pharmacokinetic and clinical studies
- Serve (with a senior mentor) as a representative on nonclinical and clinical project teams to guide clinical pharmacology and translational efforts
- Contribute towards drafting of regulatory documents
- Contribute towards writing of clinical study protocols and reports
- Execute, interpret, and present results from PK/PD and/or pop-PK analyses at internal meetings
- Present work at professional meetings and/or author a scientific publication
- Pharm.D., MD, or Ph.D. from an accredited university or equivalent
- Experience and coursework in pharmacology, pharmacokinetics, statistics, and data analytics
- Excellent oral and written communication skills, ethics, professionalism, leadership
- Research experience
- Skills in using data analysis software packages
Beam Therapeutics, established in 2018, is a pioneer in the field of genetic medicine, utilizing CRISPR base editing to create precise, permanent alterations to single bases in DNA and RNA without breaking the strands. The company's culture is characterized by a community of fearless innovators, rigorous and honest research, open-mindedness, and commitment to each other. Their competitive advantage lies in their unique delivery strategy, which includes a range of clinically validated technologies such as electroporation, nonviral, and viral delivery modalities, positioning them as a leader in the genetic medicine industry.
Company Stage
IPO
Total Funding
$689M
Headquarters
Cambridge, Massachusetts
Founded
2017